{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a bioactivity metric (IC50, Ki, Kd, EC50), a specific numeric value, and a unit for that value. The text primarily discusses definitions, methods, and general descriptions, but does not provide concrete data points with the required metrics."}
{"raw_mentions": "There are no sentences or table rows in the provided text that contain all of the required elements: a bioactivity metric (IC50, Ki, Kd, EC50), a specific numeric value associated with that metric, and a unit for that value."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a bioactivity metric (IC50, Ki, Kd, EC50), a specific numeric value, and a unit for that value. The text primarily discusses methods, compositions, and potential effects of GHRH antagonists, but does not provide concrete data points with the required metrics and units."}
{"raw_mentions": "Here are the extracted sentences with concrete data points that contain a bioactivity metric, a specific numeric value, and a unit:\n\n* The final binding affinities were expressed as IC50 values and were calculated by using the LIGAND PC computerized curve-fitting program of Munson and Rodbard as modified by McPherson (Halmos G, Rekasi Z, Szoke B, Schally AV.(1993) Receptor 3:87-97). \n* Table 6 presents the IC50 values of GHRH antagonists to membrane GHRH-receptors binding on human anterior pituitary cells. \n* <sup>a</sup> IC50 values represent mean of two to three determinations. \n\nNote that the provided text does not contain many sentences with specific numeric values and units for bioactivity metrics. The IC50 values are mentioned, but the actual values are presented in Table 6, which is not fully provided in the text snippet. If the full table were available, it would be possible to extract more specific data points."}
